Loading clinical trials...
Loading clinical trials...
Study of the Analytical Reproducibility of the Spartan FRX CYP2C19 *2,*3 and *17 Genotyping System.
Conditions
Interventions
Spartan FRX CYP2C19 Test System
Locations
3
Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Mount Sinai Services
Toronto, Ontario, Canada
Start Date
August 1, 2012
Primary Completion Date
September 1, 2012
Completion Date
November 1, 2012
Last Updated
January 7, 2013
Lead Sponsor
Spartan Bioscience Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions